Operating Cash Flow per Share: A measure of financial performance calculated as operating cash flow, expressed on a per share basis. Calculated as: Cash Flow from Operations / Weighted Average Shares Outstanding (Diluted)
Vitro Diagnostics (VODG) had Operating Cash Flow per Share of $-0.57 for the most recently reported fiscal year, ending 2025-10-31.
| Income Statement Financials | |
$2.06M |
|
$-10.87M |
|
$0.48M |
|
$1.57M |
|
$7.08M |
|
$-5.02M |
|
$-5.83M |
|
$-10.85M |
|
$-10.85M |
|
$-10.85M |
|
$-10.85M |
|
$-10.85M |
|
$-10.85M |
|
$-5.02M |
|
$-2.05M |
|
4.46M |
|
4.46M |
|
$-2.44 |
|
$-2.44 |
|
| Balance Sheet Financials | |
$0.86M |
|
$0.04M |
|
$4.07M |
|
$4.93M |
|
$5.68M |
|
$8.99M |
|
$15.58M |
|
$21.26M |
|
$-16.33M |
|
$-19.99M |
|
$-16.33M |
|
4.46M |
|
| Cash Flow Statement Financials | |
$-2.54M |
|
$-0.07M |
|
$2.64M |
|
$0.57M |
|
$0.60M |
|
$0.03M |
|
$1.30M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
0.15 |
|
-- |
|
-- |
|
-1.22 |
|
-0.59 |
|
76.50% |
|
-244.22% |
|
-244.22% |
|
-99.79% |
|
-527.60% |
|
-528.40% |
|
$-2.54M |
|
-- |
|
-- |
|
-- |
|
0.42 |
|
3.58 |
|
24.85 |
|
14.69 |
|
66.44% |
|
54.29% |
|
-220.15% |
|
147.81% |
|
$-3.66 |
|
$-0.57 |
|
|
Operating Cash Flow per Share |
$-0.57 |